Main Products/ Services/ Pipelines & Platforms
United BioPharma (UBP), as a biopharmaceutical company, we are focusing on CDMO services and developing innovative therapeutic monoclonal antibodies.
▪ Our CDMO services UBP is dedicated to the development and commercialization of biologics. ﹒ UBP supported the development projects from phase 1 to phase 3 clinical trials located in the US, China, and Asia. ﹒ UBP achieved 10 g/L in the upstream process and more than 80% recovery rate in the downstream process. ﹒ UBP established proprietary platforms to decrease fucosylation or prolong protein half-life. ﹒ UBP has manufacturing sites in Taiwan and China to support global supply from preclinical to commercial and to backup each other. The total capacity is about 10,000L. ▪ Our advanced production pipelines ﹒ UB-421; an anti-CD4 mAb to treat HIV infection ﹒ UB-621; anti-HSV mAb to treat recurrent genital herpes ﹒ UB-221; anti-IgE mAb to treat chronic spontaneous urticaria (CSU)
▪ In-/Out-Licensing ▪ CDMO